Search results for "Malattie Infettive"

showing 8 items of 198 documents

Surgical pathology and the diagnosis of invasive visceral yeast infection: two case reports and literature review

2013

Invasive mycoses are life-threatening opportunistic infections that have recently emerged as a cause of morbidity and mortality following general and gastrointestinal surgery. Candida species are the main fungal strains of gut flora. Gastrointestinal tract surgery might lead to mucosal disruption and cause Candida spp. to disseminate in the bloodstream. Here we report and discuss the peculiar clinical and morphological presentation of two cases of gastrointestinal Candida albicans lesions in patients who underwent abdominal surgery. Although in the majority of cases reported in the literature, diagnosis was made on the basis of microbiological criteria, we suggest that morphological feature…

medicine.medical_specialtyPathologyGastrointestinal candidaSettore MED/17 - Malattie InfettiveReviewGut floraSettore MED/08 - Anatomia PatologicaSurgical pathologyDiagnosismedicineIn patientSurgical pathologybiologybusiness.industryDiagnosis; Gastrointestinal candidiasis; Surgical pathology; Surgery; Emergency Medicinebiology.organism_classificationSurgical pathology Gastrointestinal candidiasis DiagnosisDermatologyCorpus albicansGastrointestinal candidiasiSettore MED/18 - Chirurgia GeneraleCandida sppEmergency MedicineSurgeryGastrointestinal tract surgeryGastrointestinal candidiasisbusinessAbdominal surgeryDiagnosi
researchProduct

Reducing the burden of Herpes Zoster in Italy.

2015

Herpes Zoster (HZ) is a viral disease with painful neuro-dermatologic manifestations. Incidence increases with age. In Italy, the estimated incidence is 6.3 cases/1000 person/year; hospital admissions are less than 2%, 69% in patients aged over 65 years. The most frequent complication of HZ is Post-Herpetic Neuralgia (PHN) characterized by metameric pain, allodynia, and hyperalgesia. In Italy 20.6% and 9.2% of HZ patients experience PHN after 3 and 6 months, respectively. Available antiviral and analgesic treatments are relatively unsatisfactory in reducing pain and length of the disease. Prevention has recently become possible with the live attenuated vaccine Oka/Merck. Clinical studies sh…

medicine.medical_specialtyPediatricsHerpes Zoster epidemiology burden prevention immunizationSettore MED/17 - Malattie InfettiveCost-Benefit AnalysisImmunologyNeuralgia PostherpeticDiseaseSettore MED/42 - Igiene Generale E ApplicataimmunizationHerpes ZosterHerpes Zoster; epidemiology; burden; prevention; immunizationburdenChickenpox VaccinepreventionEpidemiologymedicineHumansImmunology and AllergyChickenpox VaccinePharmacologyHerpes Zoster; burden; epidemiology; immunization; preventionbusiness.industryIncidenceIncidence (epidemiology)medicine.diseaseSurgeryVaccinationAllodyniaItalyNeuralgiaepidemiologyViral diseasemedicine.symptombusinessResearch Paper
researchProduct

Determinants of patient and health-care system delay in the diagnosis of tuberculosis in Sicily

2016

tuberculosis, health-care system, diagnosis

medicine.medical_specialtyPediatricsTuberculosisSettore MED/17 - Malattie Infettivebusiness.industryPublic Health Environmental and Occupational Healthmedicine.diseaseSettore MED/42 - Igiene Generale E Applicatatuberculosis health-care system diagnosisHealth careMedicinebusinessIntensive care medicine
researchProduct

Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review

2014

Diabetes is a well-known risk factor for invasive mucormycosis with rhinocerebral involvement. Acute necrosis of the maxilla is seldom seen and extensive facial bone involvement is rare in patients with rhino-orbital-cerebral mucormycosis. An aggressive surgical approach combined with antifungal therapy is usually necessary. In this report, we describe the successful, personalized medical and surgical management of extensive periorbital mucormycosis in an elderly diabetic, HIV-negative woman. Mono- or combination therapy with liposomal amphotericin B (L-AmB) and posaconazole (PSO) and withheld debridement is discussed. The role of aesthetic plastic surgery to preserve the patient’s physical…

medicine.medical_specialtyPosaconazoleDebridementFacial boneCombination therapySettore MED/17 - Malattie Infettivebusiness.industrymedicine.medical_treatmentMucormycosislcsh:RSettore MED/19 - Chirurgia Plasticalcsh:MedicineCase ReportGeneral MedicineSettore MED/08 - Anatomia Patologicamedicine.diseaseSurgerySettore MED/13 - EndocrinologiaPlastic surgeryDiabetes mellitusMedicineRhinocerebral Mucormycosis DiabetesRisk factorbusinessmedicine.drug
researchProduct

Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms.

2014

The prevalence of bacterial resistance to carbapenem antibiotics continues to increase because of bacteria producing metallo-β-lactamases (MBL), called carbapenemase-producing organisms (CPO). Enterobacteriaceae, which can be a common cause of intra-abdominal infections (IAIs), have become carbapenem-resistant Enterobacteriaceae (CRE). Updated international guidelines for the treatment of both IAIs and IAIs due to CRE have been published. Given the multifaceted nature of these infections, these recommendations have been jointly reviewed and endorsed by the Surgical Society and the Association of Medical Microbiology and Infectious Disease. The aims of this review are to summarize the genera…

medicine.medical_specialtySettore MED/17 - Malattie InfettiveIaisIntra-abdominal infections . Carbapenemase-producing organisms . Carbapenem-resistant Enterobacteriaceae . Management of intra-abdominal infectionsAbdominal InfectionCarbapenem-resistant enterobacteriaceaeBiologySettore MED/42 - Igiene Generale E ApplicataAntimicrobialbiology.organism_classificationMicrobiologySettore MED/18 - Chirurgia GeneraleInfectious DiseasesMedical microbiologyAntibiotic resistanceInfectious disease (medical specialty)medicineInfection controlIntensive care medicineCurrent infectious disease reports
researchProduct

Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study.

2011

Aim:Toxoplasma gondii infection during pregnancy poses a serious risk to the fetus, therefore timely and accurate diagnosis is essential. The aim of this study was to estimate the frequency of congenital infection via evaluating mother's immunological status and the possibility to improving the diagnostic and therapeutic approaches.Methods:Eighty five mothers with Toxoplasma seroconversion and their offspring were enrolled (among them, 2 spontaneous abortions were documented in the first trimester). Prenatal PCR diagnosis was carried out on 50 patients (60%), with 7 positive cases (14%). Morphological ultrasound scanning revealed anomalies in one fetus. Long-term follow-up included general …

medicine.medical_specialtySettore MED/17 - Malattie InfettiveOffspringToxoplasmosis gondiineurological prognosiToxoplasmosis CongenitalSerologySettore MED/38 - Pediatria Generale E SpecialisticaPregnancyPrenatal DiagnosismedicineHumansPharmacology (medical)Prospective StudiesSeroconversionProspective cohort studyChildPharmacologyFetusPregnancybiologybusiness.industryObstetricsSettore MED/30 - Malattie Apparato Visivoocular prognosiPregnancy OutcomeToxoplasma gondiiGeneral Medicinemedicine.diseasebiology.organism_classificationToxoplasmosisInfectious Disease Transmission Verticalcongenital infectionWestern blot analysisprenatal screeningChild PreschoolPregnancy Complications ParasiticImmunologyserological responseFemaleOriginal ArticlebusinessFollow-Up StudiesActa pharmacologica Sinica
researchProduct

Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects

2012

Abstract Background Despite the reported high prevalence of osteoporosis in the human immunodeficiency virus (HIV)-population, there have been no previous studies examining dairy calcium intake and bone mineral density (BMD) in HIV-subjects. We assessed the prevalence of low BMD in HIV-infected and uninfected subjects and analyzed the effects of calcium intake, lifestyle and HIV-related risk factors on BMD. Methods One hundred and twelve HIV-infected subjects were consecutively enrolled. Seventy- six HIV-uninfected subjects matched for age and sex were enrolled as the control group. The HIV-subjects were interviewed about lifestyle habits and completed a weekly food-frequency questionnaire …

musculoskeletal diseasesAdultMalemedicine.medical_specialtyFRAXSettore MED/09 - Medicina InternaBone densitySettore MED/17 - Malattie InfettiveOsteoporosisHIV Infectionslcsh:Infectious and parasitic diseasesBone remodelingAbsorptiometry PhotonBone DensityRisk FactorsSurveys and QuestionnairesInternal medicineVitamin D and neurologyBone mineral densityHumansMedicinelcsh:RC109-216Life StyleBone mineralMediterranean Regionbusiness.industryOsteopeniaCase-control studyOsteoporosiHIVMiddle AgedDairy intakemedicine.diseaseDietOsteopeniaInfectious DiseasesEndocrinologyCase-Control StudiesOsteoporosisCalciumFemalebusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaResearch Article
researchProduct

Liver disease severity and low bone mineral density in HIV mono-infected and HIV/HCV co-infected patients

2014

Background: In this study we assess: prevalence of osteopenia, osteoporosis and reduced bone mineral density in HIV infection and HIV / HCV co-infection;risk factors associated with reduced bone mineral density(BMD); relationship between bone mineral density and reduced liver fibrosis (FE) measured as "liver stiffness" (LS), by FibroScan ® in patients co-infected with HIV / HCV; relationship between reduced bone mineral density and cardiovascular risk assessed with the 10-year Framingham risk score (FRS) in HIV / HCV co-infected Patients And Methods: One hundred and ninety-four HIV-infected subjects (121 males =62% and 73 females = 38 %): 129 HIV-infected ( 66.5 % ) and 65 HIV / HCV co-infe…

osteoporosis Liver diseaseSettore MED/12 - GastroenterologiaSettore MED/09 - Medicina InternaSettore MED/17 - Malattie InfettiveSettore MED/42 - Igiene Generale E ApplicataHIV / HCV co-infected
researchProduct